Hero

Celyad Reports First Half 2016 Financial Results and Operational Progress

1

Celyad Reports First Half 2016 Financial Results and Operational Progress

Developing breakthrough pioneering therapies for life-threatening diseases

2

Developing breakthrough pioneering therapies for life-threatening diseases

Directing a weaponized attack on cancer with the NKR-T cell immunotherapy

3

Directing a weaponized attack on cancer with the NKR-T cell immunotherapy

Celyad enters into license agreement with ONO PHARMACEUTICAL CO., LTD

4

Celyad enters into license agreement with ONO PHARMACEUTICAL CO., LTD

About Celyad

Driven by a passion to invent

Celyad is a clinical-stage biopharmaceutical company focused on the discovery and development of breakthrough pioneering cell-based therapies for life-threatening diseases.

More info about Celyad

Latest News

Celyad completes the NKR-2 Phase I trial with successful safety follow-up of the fourth dose level

Celyad completes the NKR-2 Phase I trial with successful safety follow-up of the fourth dose level

Celyad appoints Philippe Dechamps as General Counsel and Company Secretary

Celyad appoints Philippe Dechamps as General Counsel and Company Secretary

Celyad CEO to present at the 2016 Cell & Gene Meeting on the Mesa

Celyad CEO to present at the 2016 Cell & Gene Meeting on the Mesa

Discover all news

Carousel

Social Feed

[VIDEO] How normal cells become #Cancer cells? How they escape the #immunesystem to spread across the body? https://t.co/kA30K8yZ11 #Celyad

2 days ago

[VIDEO] How normal cells become #Cancer cells? How they escape the #immunesystem to spread across the body? https://t.co/kA30K8yZ11 #Celyad

What is cancer? Celyad video

2 days ago

What is cancer? Celyad video

RT @QA_Belgium: Live: Armer le système immunitaire pour combattre le cancer @ChristianHomsy @CelyadSA @QA_Belgium https://t.co/QivgD0xleJ

2 days ago

RT @QA_Belgium: Live: Armer le système immunitaire pour combattre le cancer @ChristianHomsy @CelyadSA @QA_Belgium https://t.co/QivgD0xleJ

Celyad launches a series of educational #videos about cancer, #immunotherapy and the #NKRT technology https://t.co/wdvVztwM3H #Cancer

4 days ago

Celyad launches a series of educational #videos about cancer, #immunotherapy and the #NKRT technology https://t.co/wdvVztwM3H #Cancer

[VIDEO] How normal cells become #Cancer cells? How they escape the #immunesystem to spread across the body? https://t.co/kA30K8yZ11 #Celyad

2 days ago

[VIDEO] How normal cells become #Cancer cells? How they escape the #immunesystem to spread across the body? https://t.co/kA30K8yZ11 #Celyad

RT @QA_Belgium: Live: Armer le système immunitaire pour combattre le cancer @ChristianHomsy @CelyadSA @QA_Belgium https://t.co/QivgD0xleJ

2 days ago

RT @QA_Belgium: Live: Armer le système immunitaire pour combattre le cancer @ChristianHomsy @CelyadSA @QA_Belgium https://t.co/QivgD0xleJ

Celyad launches a series of educational #videos about cancer, #immunotherapy and the #NKRT technology https://t.co/wdvVztwM3H #Cancer

4 days ago

Celyad launches a series of educational #videos about cancer, #immunotherapy and the #NKRT technology https://t.co/wdvVztwM3H #Cancer

@Celyad at #CARTCR16 : Safety Data from #NKR2 Phase I Trial in AML/MDS and MM https://t.co/H8GQi5XEWo #immunotherapy https://t.co/chaPHKnYJG

1 week ago

@Celyad at #CARTCR16 : Safety Data from #NKR2 Phase I Trial in AML/MDS and MM https://t.co/H8GQi5XEWo #immunotherapy https://t.co/chaPHKnYJG

What is cancer? Celyad video

2 days ago

What is cancer? Celyad video

Celyad launches a series of educational videos

4 days ago

Celyad launches a series of educational videos

Safety data from Celyad's NKR-2 Phase I trial in AML/MDS and MM

1 week ago

Safety data from Celyad's NKR-2 Phase I trial in AML/MDS and MM

Celyad CEO to present at the 2016 Cell & Gene Meeting on the Mesa

1 week ago

Celyad CEO to present at the 2016 Cell & Gene Meeting on the Mesa